Cookie Settings
We use cookies to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement and Cookie Statement.
Isolation of PTK7 (CCK-4) + cells from PBMCs using the Anti-PTK7 (CCK-4) MicroBead Kit and a MiniMACS™ Separator with MS Columns. Aliquots are fluorescently stained (A) before and (B) after magnetic separation with CD34-FITC, CD303 (BDCA-2)-PE and CD141 (BDCA-3)-APC for identification of hematopoietic stem cells (HPCs), plasmacytoid dendritic cells (PDCs), and type-2 myeloid dendritic cells (MDC2), respectively. Before and after separation, cells were gated on R1 (PDCs), R2 (HPCs), and R3 (MDC2s). Due to specific expression of CD303 (BDCA-2), CD141 (BDCA-3), and CD34 there is no overlap between the different PTK7-expressing cell types, and PDCs, HPCs, and MDC2s are clearly discriminated. |
A) Before magnetic separation | |
Identification of PDCs and HPCs | Identification of MDC2s |
Anti-PTK7 (CCK-4) MicroBead Kit, humanFigure 1Isolation of PTK7 (CCK-4) + cells from PBMCs using the Anti-PTK7 (CCK-4) MicroBead Kit and a MiniMACS™ Separator with MS Columns. Aliquots are fluorescently stained (A) before and (B) after magnetic separation with CD34-FITC, CD303 (BDCA-2)-PE and CD141 (BDCA-3)-APC for identification of hematopoietic stem cells (HPCs), plasmacytoid dendritic cells (PDCs), and type-2 myeloid dendritic cells (MDC2), respectively. Before and after separation, cells were gated on R1 (PDCs), R2 (HPCs), and R3 (MDC2s). Due to specific expression of CD303 (BDCA-2), CD141 (BDCA-3), and CD34 there is no overlap between the different PTK7-expressing cell types, and PDCs, HPCs, and MDC2s are clearly discriminated. | Anti-PTK7 (CCK-4) MicroBead Kit, humanFigure 1Isolation of PTK7 (CCK-4) + cells from PBMCs using the Anti-PTK7 (CCK-4) MicroBead Kit and a MiniMACS™ Separator with MS Columns. Aliquots are fluorescently stained (A) before and (B) after magnetic separation with CD34-FITC, CD303 (BDCA-2)-PE and CD141 (BDCA-3)-APC for identification of hematopoietic stem cells (HPCs), plasmacytoid dendritic cells (PDCs), and type-2 myeloid dendritic cells (MDC2), respectively. Before and after separation, cells were gated on R1 (PDCs), R2 (HPCs), and R3 (MDC2s). Due to specific expression of CD303 (BDCA-2), CD141 (BDCA-3), and CD34 there is no overlap between the different PTK7-expressing cell types, and PDCs, HPCs, and MDC2s are clearly discriminated. |
Discrimination between PTK7-expressing cell types | |
Anti-PTK7 (CCK-4) MicroBead Kit, humanFigure 1Isolation of PTK7 (CCK-4) + cells from PBMCs using the Anti-PTK7 (CCK-4) MicroBead Kit and a MiniMACS™ Separator with MS Columns. Aliquots are fluorescently stained (A) before and (B) after magnetic separation with CD34-FITC, CD303 (BDCA-2)-PE and CD141 (BDCA-3)-APC for identification of hematopoietic stem cells (HPCs), plasmacytoid dendritic cells (PDCs), and type-2 myeloid dendritic cells (MDC2), respectively. Before and after separation, cells were gated on R1 (PDCs), R2 (HPCs), and R3 (MDC2s). Due to specific expression of CD303 (BDCA-2), CD141 (BDCA-3), and CD34 there is no overlap between the different PTK7-expressing cell types, and PDCs, HPCs, and MDC2s are clearly discriminated. | |
B) Enriched PTK7 (CCK-4)+ cells | |
Identification of PDCs and HPCs | Identification of MDC2s |
Anti-PTK7 (CCK-4) MicroBead Kit, humanFigure 1Isolation of PTK7 (CCK-4) + cells from PBMCs using the Anti-PTK7 (CCK-4) MicroBead Kit and a MiniMACS™ Separator with MS Columns. Aliquots are fluorescently stained (A) before and (B) after magnetic separation with CD34-FITC, CD303 (BDCA-2)-PE and CD141 (BDCA-3)-APC for identification of hematopoietic stem cells (HPCs), plasmacytoid dendritic cells (PDCs), and type-2 myeloid dendritic cells (MDC2), respectively. Before and after separation, cells were gated on R1 (PDCs), R2 (HPCs), and R3 (MDC2s). Due to specific expression of CD303 (BDCA-2), CD141 (BDCA-3), and CD34 there is no overlap between the different PTK7-expressing cell types, and PDCs, HPCs, and MDC2s are clearly discriminated. | Anti-PTK7 (CCK-4) MicroBead Kit, humanFigure 1Isolation of PTK7 (CCK-4) + cells from PBMCs using the Anti-PTK7 (CCK-4) MicroBead Kit and a MiniMACS™ Separator with MS Columns. Aliquots are fluorescently stained (A) before and (B) after magnetic separation with CD34-FITC, CD303 (BDCA-2)-PE and CD141 (BDCA-3)-APC for identification of hematopoietic stem cells (HPCs), plasmacytoid dendritic cells (PDCs), and type-2 myeloid dendritic cells (MDC2), respectively. Before and after separation, cells were gated on R1 (PDCs), R2 (HPCs), and R3 (MDC2s). Due to specific expression of CD303 (BDCA-2), CD141 (BDCA-3), and CD34 there is no overlap between the different PTK7-expressing cell types, and PDCs, HPCs, and MDC2s are clearly discriminated. |
Discrimination between PTK7-expressing cell types | |
Anti-PTK7 (CCK-4) MicroBead Kit, humanFigure 1Isolation of PTK7 (CCK-4) + cells from PBMCs using the Anti-PTK7 (CCK-4) MicroBead Kit and a MiniMACS™ Separator with MS Columns. Aliquots are fluorescently stained (A) before and (B) after magnetic separation with CD34-FITC, CD303 (BDCA-2)-PE and CD141 (BDCA-3)-APC for identification of hematopoietic stem cells (HPCs), plasmacytoid dendritic cells (PDCs), and type-2 myeloid dendritic cells (MDC2), respectively. Before and after separation, cells were gated on R1 (PDCs), R2 (HPCs), and R3 (MDC2s). Due to specific expression of CD303 (BDCA-2), CD141 (BDCA-3), and CD34 there is no overlap between the different PTK7-expressing cell types, and PDCs, HPCs, and MDC2s are clearly discriminated. |
Isolation of PTK7 (CCK-4) + cells from PBMCs using the Anti-PTK7 (CCK-4) MicroBead Kit and a MiniMACS™ Separator with MS Columns. Aliquots are fluorescently stained (A) before and (B) after magnetic separation with CD34-FITC, CD303 (BDCA-2)-PE and CD141 (BDCA-3)-APC for identification of hematopoietic stem cells (HPCs), plasmacytoid dendritic cells (PDCs), and type-2 myeloid dendritic cells (MDC2), respectively. Before and after separation, cells were gated on R1 (PDCs), R2 (HPCs), and R3 (MDC2s). Due to specific expression of CD303 (BDCA-2), CD141 (BDCA-3), and CD34 there is no overlap between the different PTK7-expressing cell types, and PDCs, HPCs, and MDC2s are clearly discriminated. |
A) Before magnetic separation | |
Identification of PDCs and HPCs | Identification of MDC2s |
Anti-PTK7 (CCK-4) MicroBead Kit, humanFigure 1Isolation of PTK7 (CCK-4) + cells from PBMCs using the Anti-PTK7 (CCK-4) MicroBead Kit and a MiniMACS™ Separator with MS Columns. Aliquots are fluorescently stained (A) before and (B) after magnetic separation with CD34-FITC, CD303 (BDCA-2)-PE and CD141 (BDCA-3)-APC for identification of hematopoietic stem cells (HPCs), plasmacytoid dendritic cells (PDCs), and type-2 myeloid dendritic cells (MDC2), respectively. Before and after separation, cells were gated on R1 (PDCs), R2 (HPCs), and R3 (MDC2s). Due to specific expression of CD303 (BDCA-2), CD141 (BDCA-3), and CD34 there is no overlap between the different PTK7-expressing cell types, and PDCs, HPCs, and MDC2s are clearly discriminated. | Anti-PTK7 (CCK-4) MicroBead Kit, humanFigure 1Isolation of PTK7 (CCK-4) + cells from PBMCs using the Anti-PTK7 (CCK-4) MicroBead Kit and a MiniMACS™ Separator with MS Columns. Aliquots are fluorescently stained (A) before and (B) after magnetic separation with CD34-FITC, CD303 (BDCA-2)-PE and CD141 (BDCA-3)-APC for identification of hematopoietic stem cells (HPCs), plasmacytoid dendritic cells (PDCs), and type-2 myeloid dendritic cells (MDC2), respectively. Before and after separation, cells were gated on R1 (PDCs), R2 (HPCs), and R3 (MDC2s). Due to specific expression of CD303 (BDCA-2), CD141 (BDCA-3), and CD34 there is no overlap between the different PTK7-expressing cell types, and PDCs, HPCs, and MDC2s are clearly discriminated. |
Discrimination between PTK7-expressing cell types | |
Anti-PTK7 (CCK-4) MicroBead Kit, humanFigure 1Isolation of PTK7 (CCK-4) + cells from PBMCs using the Anti-PTK7 (CCK-4) MicroBead Kit and a MiniMACS™ Separator with MS Columns. Aliquots are fluorescently stained (A) before and (B) after magnetic separation with CD34-FITC, CD303 (BDCA-2)-PE and CD141 (BDCA-3)-APC for identification of hematopoietic stem cells (HPCs), plasmacytoid dendritic cells (PDCs), and type-2 myeloid dendritic cells (MDC2), respectively. Before and after separation, cells were gated on R1 (PDCs), R2 (HPCs), and R3 (MDC2s). Due to specific expression of CD303 (BDCA-2), CD141 (BDCA-3), and CD34 there is no overlap between the different PTK7-expressing cell types, and PDCs, HPCs, and MDC2s are clearly discriminated. | |
B) Enriched PTK7 (CCK-4)+ cells | |
Identification of PDCs and HPCs | Identification of MDC2s |
Anti-PTK7 (CCK-4) MicroBead Kit, humanFigure 1Isolation of PTK7 (CCK-4) + cells from PBMCs using the Anti-PTK7 (CCK-4) MicroBead Kit and a MiniMACS™ Separator with MS Columns. Aliquots are fluorescently stained (A) before and (B) after magnetic separation with CD34-FITC, CD303 (BDCA-2)-PE and CD141 (BDCA-3)-APC for identification of hematopoietic stem cells (HPCs), plasmacytoid dendritic cells (PDCs), and type-2 myeloid dendritic cells (MDC2), respectively. Before and after separation, cells were gated on R1 (PDCs), R2 (HPCs), and R3 (MDC2s). Due to specific expression of CD303 (BDCA-2), CD141 (BDCA-3), and CD34 there is no overlap between the different PTK7-expressing cell types, and PDCs, HPCs, and MDC2s are clearly discriminated. | Anti-PTK7 (CCK-4) MicroBead Kit, humanFigure 1Isolation of PTK7 (CCK-4) + cells from PBMCs using the Anti-PTK7 (CCK-4) MicroBead Kit and a MiniMACS™ Separator with MS Columns. Aliquots are fluorescently stained (A) before and (B) after magnetic separation with CD34-FITC, CD303 (BDCA-2)-PE and CD141 (BDCA-3)-APC for identification of hematopoietic stem cells (HPCs), plasmacytoid dendritic cells (PDCs), and type-2 myeloid dendritic cells (MDC2), respectively. Before and after separation, cells were gated on R1 (PDCs), R2 (HPCs), and R3 (MDC2s). Due to specific expression of CD303 (BDCA-2), CD141 (BDCA-3), and CD34 there is no overlap between the different PTK7-expressing cell types, and PDCs, HPCs, and MDC2s are clearly discriminated. |
Discrimination between PTK7-expressing cell types | |
Anti-PTK7 (CCK-4) MicroBead Kit, humanFigure 1Isolation of PTK7 (CCK-4) + cells from PBMCs using the Anti-PTK7 (CCK-4) MicroBead Kit and a MiniMACS™ Separator with MS Columns. Aliquots are fluorescently stained (A) before and (B) after magnetic separation with CD34-FITC, CD303 (BDCA-2)-PE and CD141 (BDCA-3)-APC for identification of hematopoietic stem cells (HPCs), plasmacytoid dendritic cells (PDCs), and type-2 myeloid dendritic cells (MDC2), respectively. Before and after separation, cells were gated on R1 (PDCs), R2 (HPCs), and R3 (MDC2s). Due to specific expression of CD303 (BDCA-2), CD141 (BDCA-3), and CD34 there is no overlap between the different PTK7-expressing cell types, and PDCs, HPCs, and MDC2s are clearly discriminated. |
Seems like you are coming from USA!
Do you want to visit our website in your country?
Copyright © 2022 Miltenyi Biotec and/or its affiliates. All rights reserved.